OmniParticles
Pharmaceutical Manufacturing • 
20, Seongsui-ro 7-gil, Korea, Republic of • 1-10 Employees
Company overview
| Headquarters | 20, Seongsui-ro 7-gil, 4F, Seoul, 04781, KR |
| Website | |
| NAICS | 3254 |
| Keywords | CMC, GMP, Nanomedicine, Nanoparticles, Cdmo, LNP, Regulatory Support, Scale Up, Inorganic, Concept Translation, Formulation Refinement |
| Employees | 1-10 |
Key Contact at OmniParticles
Seung Hoon Lee
Ceo
About OmniParticles
OmniParticles is a full-service CDMO specialized in nanomedicine. We provide formulation development, scale-up, GMP-compliant manufacturing, and regulatory CMC support for companies developing: - Inorganic nanoparticles (e.g., iron oxide, gold, cerium oxide, etc.) - Nanozyme-based therapeutics - LNPs and polymeric nanocarriers - Complex nanoparticle delivery systems Headquartered in Seoul with FDA-compliant capabilities, we help early-stage companies and research teams translate nanoparticle-based drug concepts into clinical-ready therapeutics. Core services: ✅ Translation from concept ✅ Formulation refinement ✅ Scale-up process development ✅ Mass production (GMP) ✅ CMC Regulatory support
OmniParticles revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
OmniParticles has 4 employees across 3 departments.
Departments
Number of employees
Funding Data
OmniParticles has never raised funding before.
United Arab Emirates
United States
United Kingdom
Norway
China
Italy
CanadaFrequently asked questions
4.8
40,000 users
